Search Courses

Liver-Directed Therapies Update

Course Details

Contact Hour(s): 1.0

Available Until: 8/14/2022

Non-Member Price: FREE

Add to My Courses

Date: Friday, October 30, 2020

Time: 12:00 PM ET

Learning Outcomes

  1. Explain the role of liver directed therapy in patients with metastatic neuroendocrine tumors to liver
  2. Describe the use of embolization of liver metastases associated with NETs
  3. Discuss the different types of embolotherapy-TACE,Bland,TARE
  4. Explain post-embolization syndrome, complications, and management
  5. Discuss current trials and relevant research study involving embolization
  6. Describe the role of percutaneous ablation in patients who are not candidates for surgical resection

About the Speaker- Michael C Soulen, MD & Diana van Houten, CRNP

Dr. Michael Soulen is Professor of Radiology and Surgery and Director of Interventional Oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, where he has been on the faculty for 25 years. Dr. Soulen is a graduate of Yale University and the University of Pennsylvania School of Medicine. He was Chief Resident in Radiology at The Johns Hopkins Hospital, followed by clinical and research Fellowships at Thomas Jefferson University Hospital before coming to Penn Medicine.

Diana van Houten has been an NP in IR for 9 years. Prior to that, she worked as a surgical/trauma ICU nurse for 5 years and prior to that in medical oncology. Her role in IR is to see patients in their outpatient clinic in evaluation for liver-directed therapies-pre and post-procedure. She also manage procedure-related symptoms, i.e. post embolization syndrome.

Guerbet is one of the leading experts in medical imaging worldwide. Collectively, Guerbet offers a full range of medical solutions and services in diagnostic imaging and interventional imaging. Learn more.

 

Accreditation Valid until August 14, 2022.